Search

everythinglearnresearchcommunity

for

Search:↓

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Bupropion may help treat trichotillomania when fluoxetine doesn't work.

Tridax procumbens plant parts boost immune response in mice.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

CD4+ skin cells may be precursors to basal cell carcinoma.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

The new drug delivery system effectively targets lung cancer cells.

Puerariae Lobatae Radix can reduce sebaceous gland size and secretion, potentially treating related skin conditions.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

*Laportea bulbifera* contains unique compounds that may help treat benign prostatic hyperplasia.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.